HOME >> MEDICINE >> NEWS
Leading immunosuppressant CellCept significantly extends the lifespan of transplanted kidneys

The analysis showed that after three years treatment with CellCept + tacrolimus, kidney survival was 85.9% versus 80.3% with patients taking sirolimus + tacrolimus immunosuppressants. The outcome was even better for higher risk patients with a kidney survival rate of 74.5% vs 57.5%[i]. The new data were presented at the European Society for Organ Transplantation (ESOT), Geneva, Switzerland. Previous data have shown that CellCept gives a survival benefit when compared to older immunosuppressant drugs and now these new data demonstrate the survival benefit of CellCept combinations over the newer drug regimens.

Kidneys are the most commonly transplanted organs[ii]; for every kidney available there are four people waiting to receive one[iii]. After transplantation, people need to take a combination of immunosuppressant drugs for the rest of their lives to prevent the body rejecting the new organ. By preserving the transplanted organ with CellCept based combinations, doctors can help patients to keep their organs longer, thereby, reducing the burden on the already limited donor pool. One way to achieve this is by choosing combinations based on the low toxicity profile of CellCept, along with reduced doses of the more toxic immunosuppressant drugs to decrease the risk of losing the new kidney.

"We have learnt that the combination of cyclosporine/sirolimus is toxic to the kidney over time and as a result some doctors have switched to a sirolimus/tacrolimus combination, that was perceived to be less toxic," said Prof Herwig-Ulf Meier Kriesche, University of Florida, Gainesville, Fl, USA. "Now we have the data to show that this combination is just as damaging. These data, along with this latest analysis of patients on CellCept combinations, should help us make an evidence-based choice on how best to reduce the risk of toxicity, which we know is associated with some long-term immunosuppressant regimens," he added.


'"/>

Contact: Helen Swift
helen.swift@ketchum.com
+44-20-7611-3637
Ketchum
19-Oct-2005


Page: 1

Related medicine news :

1. Leading prevention researchers meeting in Washington, D.C., May 30-June 1, 2007
2. Leading advocates express support for microbicide research, despite disappointing trial results
3. Leading European experts in magnetic resonance for animals
4. Leading healthcare authorities to address safety and effectiveness
5. Leading international osteoporosis experts to present at worlds largest osteoporosis congress
6. Leading hepatology textbook edited by SLU researchers
7. Leading groups offer NIH direct links to journals to make research access easy for public
8. Leading pediatricians group recommends infants sleep in cribs, not parents beds
9. Leading genomic technology expert to present Dickson Prize Lecture at Pitt
10. Leading experts discuss how to protect premature infants against RSV, a potentially dangerous virus
11. Leading sleep expert at Wake Forest to speak at NIH Consensus Conference

Post Your Comments:
(Date:7/29/2015)... ... July 29, 2015 , ... Today marks a significant achievement in bringing new ... companies and is led by a group of experienced investors, has tapped into an ... their dollars to be a part of the fund. The Sofia Fund II ...
(Date:7/29/2015)... ... July 29, 2015 , ... Fastline ... fall of 2015 on RFD-TV. , Fastline is dedicated to quality agricultural advertising, ... which contains the largest and freshest searchable agriculture equipment database in the world. ...
(Date:7/29/2015)... ... ... It is unique for a health center to dedicate a full-time medical ... is very hands on and resident oriented, and one to which Dr. Rennecker is ... and energy, as well as a strong commitment to helping seniors live longer, healthier ...
(Date:7/29/2015)... ... July 29, 2015 , ... TransFlip is an all new dynamic transition pack ... for FCPX, these transitions are easy to apply and modify for any skill-level user. ... over 60 preset styles, kinetic flipping panel animations are just a few clicks away. ...
(Date:7/29/2015)... ... July 29, 2015 , ... The New Foundation AZ recently ... the end will cost the 501(c) organization nearly $1 million, will both update the ... , “We took it down to the studs,” said Geraldine Leary, the New Foundation ...
Breaking Medicine News(10 mins):Health News:Sofia Fund Surpasses Investor Goals 2Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 3Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3
(Date:7/29/2015)... -- The Perinatal Quality Foundation (PQF) today announced a ... limitations and clinically appropriate interpretation of results of ... pregnant women and their healthcare providers. Quest Diagnostics ... of diagnostic information services, is the first commercial ... Through a comprehensive education and ...
(Date:7/29/2015)... 29, 2015 /PRNewswire/-- LabStyle Innovations Corp. (DRIO), today announced that ... broadcast news segment in Australia .  The ... following regulatory and reimbursement approval in that country. ... Australians living with diabetes. As a case in point, the ... for a 13 year old boy with Type 1 diabetes ...
(Date:7/29/2015)... July 29, 2015 Breckenridge Pharmaceutical, Inc. ... Nasal Solution, 0.1%. The U.S. Food and Drug Administration ... (ANDA), which is AB rated to Astelin®, a ... solution (nasal spray) is a $69 million dollar ... sales data.  Azelastine HCl Nasal Solution is indicated ...
Breaking Medicine Technology:Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 2Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 3Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 4LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 2LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 3
Cached News: